StockTipsArenaBeta

BUY Gland Pharma Limited — Sumeet Bagadia, Choice Broking

BUYGland Pharma Limited

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))30 Jul 2026via LiveMint Buy-or-Sell (topic)

Entry₹2,544Stated
Target₹2,720
Total upside +6.92% (call closed)
Stop loss₹2,434-4.32% risk
Exit₹2,72011 Aug 2026, 9:15 am
Target hit+6.92%0.00%upside left
Follow Sumeet Bagadia for new calls(31% target hit, 263 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 99 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 11 Aug 2026
10 supporting2 neutral2 opposing
Supports the BUY call (10)

Gland Pharma Delivers Q1 Earnings Beat On US, Europe Strength; Motilal Oswal Raises Estimates — Check New Target Price

NewsNdtv-Profit·11 Aug · today

(opens in new tab)

Gland Pharma Q1 Results: Profit Spikes 47% As Margins Expand; Revenue Hits Rs 1,800 Crore

NewsNdtv-Profit·10 Aug · today

(opens in new tab)

Gland Pharma Q1 net profit jumps 47% on strong CDMO, B2B performance; revenue up 20%

NewsCnbc-Tv18·10 Aug · today

(opens in new tab)

Gland Pharma Q1 Results: Net profit jumps 47% YoY to ₹317 crore; CDMO revenue rises 20%

NewsLivemint·10 Aug · today

(opens in new tab)

Gland Pharma reported Q1FY27 financial results, showing a 20% year-on-year revenue growth and a 47% year-on-year PAT growth. The company highlighted strong performance driven by its CDMO strategy and

BSE · Company Update·10 Aug · today

(opens in new tab)
Neutral / worth noting (2)

Gland Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.

NSE · Outcome of Board Meeting·10 Aug · today

(opens in new tab)

Corporate Actions This Week: Indus Towers, PTC India, Gland Pharma, HAL, HPCL, REC | Full List

NewsNdtv-Profit·9 Aug · yesterday

(opens in new tab)
Weighs against the BUY call (2)

Q1 Results Today Highlights: Bharat Forge shares tank after Q1 loss, Kwality Pharma, Ramco Industries Q1 PAT up, Hindustan Copper PAT down q-o-q, AstraZeneca, Info Edge & Astra Microwave profit dip, Vi, Bosch, Lloyds Metals, Gland Pharma, Zee Entertainment, KEC International to announce Q1 results

NewsHbl·10 Aug · today

(opens in new tab)

Gland Pharma, Lupin, Dr Reddy's: All Nifty Pharma Stocks In Red After Trump's Drug Tariff Plan

NewsNdtv-Profit·22 Jul · 3w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.